Example: Heart Attack

Search clinical trials for: Cyclophosphamide

Total 3674 results

NCT04464434

Not yet recruiting

Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Conditions: Systemic Sclerosis; Systemic Scleroses, Diffuse; Scleroderma; Scleroderma, Diffuse; Autologous Stem Cell Transplantation; Cyclophosphamide; Mycophenolate Mofetil; Treatment Strategy
NCT04447547

Recruiting

Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Conditions: Non-hodgkin's Lymphoma
NCT04447573

Recruiting

Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Conditions: Multiple Myeloma
NCT04443348

Not yet recruiting

Pre-op Pembro + Radiation Therapy in Breast Cancer

Conditions: Triple Negative Breast Cancer; Hormone Receptor Positive (HR+), HER2-negative Breast Cancer; Biopsy-proven, Positive Lymph Node(s)
NCT04438603

Recruiting

The Role of T/B Cell Repertoire in Non-invasive Diagnosis and Disease Monitoring in Patients With IgA Nephropathy

Conditions: IgA Nephropathy
NCT04440267

Not yet recruiting

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Conditions: Acute Leukemia of Ambiguous Lineage
NCT04440436

Recruiting

Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients

Conditions: NHL
NCT04437160

Recruiting

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Conditions: Triple Negative Breast Cancer
NCT04432506

Not yet recruiting

Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma

Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
NCT04432714

Recruiting

Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement

Conditions: DLBCL; Untreated; MYC Gene Rearrangement
NCT04433156

Recruiting

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Conditions: Marginal Zone Lymphoma
NCT04424602

Not yet recruiting

Comparison between2 Drugs in Lupus Nephritis

Conditions: Lupus Nephritis
NCT04424862

Not yet recruiting

Multitarget Therapy for Idiopathic Membranous Nephropathy

Conditions: Efficacy
NCT04426669

Recruiting

A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Conditions: Gastrointestinal Epithelial Cancer; Gastrointestinal Neoplasms; Cancer of Gastrointestinal Tract; Cancer, Gastrointestinal; Gastrointestinal Cancer; Colo-rectal Cancer; Pancreatic Cancer; Gall Bladder Cancer; Colon Cancer; Esophageal Cancer; Stomach Cancer
NCT04423926

Recruiting

Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

Conditions: PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATL
NCT04418154

Recruiting

Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients

Conditions: Triple Negative Breast Cancer
NCT04418219

Not yet recruiting

A Breast Cancer Vaccine (SV-BR-1-GM) in Combination With Pembrolizumab for the Treatment of Persistent, Recurrent, or Metastatic Breast Cancer

Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Breast Carcinoma; Refractory Breast Carcinoma
NCT04416984

Recruiting

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma (ALPHA-2)

Conditions: Relapsed/Refractory Large B Cell Lymphoma
NCT04404660

Recruiting

A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

Conditions: Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
NCT04398914

Recruiting

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Conditions: Breast Cancer Invasive
NCT04400045

Recruiting

Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome

Conditions: Nijmegen Breakage Syndrome
NCT04392648

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Conditions: Relapsed and/or Refractory Multiple Myeloma
NCT04394650

Not yet recruiting

A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed and/or Refractory Multiple Myeloma

Conditions: Multiple Myeloma
NCT04392037

Not yet recruiting

Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone

Conditions: Multiple Myeloma
NCT04389229

Not yet recruiting

OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)

Conditions: Ovarian Cancer Metastatic
NCT04390399

Recruiting

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for First and Second Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Conditions: Pancreatic Cancer
NCT04387630

Recruiting

Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

Conditions: Breast Cancer
NCT04388839

Not yet recruiting

Evolutionary Therapy for Rhabdomyosarcoma

Conditions: Rhabdomyosarcoma
NCT04385641

Recruiting

Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer

Conditions: Advanced Gastric Cancer; Gastroesophageal Cancer
NCT04384692

Not yet recruiting

Ruxolitinib for the Treatment of Graft Versus Host Disease Following Stem Cell Transplant in Patients With Primary and Secondary Myelofibrosis

Conditions: Primary Myelofibrosis; Secondary Myelofibrosis
NCT04380831

Recruiting

TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis

Conditions: Systemic Scleroderma
NCT04377932

Not yet recruiting

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Conditions: Liver Cancer; Rhabdomyosarcoma; Malignant Rhabdoid Tumor; Liposarcoma; Wilms Tumor; Yolk Sac Tumor
NCT04375631

Not yet recruiting

CLAG-M Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Conditions: Acute Leukemia of Ambiguous Lineage; Recurrent Acute Myeloid Leukemia; Recurrent Acute Undifferentiated Leukemia; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelomonocytic Leukemia; Refractory Mixed Phenotype Acute Leukemia; Refractory Myelodysplastic Syndrome
NCT04372615

Not yet recruiting

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

Conditions: Autoimmune Encephalitis; Encephalitis
NCT04373031

Not yet recruiting

Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer

Conditions: Breast Cancer; Breast Neoplasms
NCT04369495

Not yet recruiting

BAFF Levels and Lupus Nephritis (LN)

Conditions: Lupus Nephritis
NCT04370301

Not yet recruiting

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Conditions: Primary Myelofibrosis; Secondary Myelofibrosis
NCT04361058

Recruiting

Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide

Conditions: Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Myelodysplastic Syndrome Acute Myeloid Leukemia
NCT04361279

Recruiting

A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL

Conditions: Diffuse Large B-Cell Lymphoma
NCT04362293

Recruiting

Reduced Intensity Transplantation for Severe Sickle Cell Disease

Conditions: Sickle Cell Disease
NCT04350021

Recruiting

Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer

Conditions: Breast Cancer Metastatic; Chemotherapy Effect
NCT04347616

Not yet recruiting

Natural Killer-cell Therapy for Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia, Relapsed, Adult
NCT04348006

Recruiting

Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients

Conditions: Newly Diagnosed Multiple Myeloma
NCT04339777

Not yet recruiting

Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases

Conditions: Lymphoproliferative Disorders; Autoimmune Lymphoproliferative; Immune System Diseases; Common Variable Immunodeficiency; Primary T-cell Immunodeficiency Disorders
NCT04340154

Recruiting

Study of Sequential CAR-T Cell Treating Leukemia Children

Conditions: Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse; Refractory Acute Lymphoid Leukemia
NCT04340167

Recruiting

Study of Anti-CD22 CAR-T Cells Treating Leukemia Children

Conditions: Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse; Refractory Acute Lymphoblastic Leukemia
NCT04336501

Recruiting

Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation

Conditions: Leukemia
NCT04335669

Recruiting

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Conditions: Breast Cancer; Triple Negative Breast Neoplasms
NCT04332822

Not yet recruiting

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

Conditions: DLBCL; Diffuse Large B Cell Lymphoma
NCT04325841

Recruiting

Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children

Conditions: Acute Lymphoblastic Leukemia, Pediatric; Acute Lymphoblastic Leukemia, in Relapse; Refractory Acute Lymphoblastic Leukemia

Search clinical trials for: Cyclophosphamide

Recent CRA jobs

Business Analyst (Salesforce)

Site Management Coordinator (Cape Town, Centurion or Bloemfontein based)

Dev Opns Engineer

Business Analyst - SaaS CRMs (Salesforce)

Centralized Monitoring Lead (Homebased)

Freelance- Translators/Linguists, Polish language

Jovem Aprendiz

Senior/Safety Specialist (Home/Office-Based) - IQVIA Biotech

Patient Pathway and Support Program Internship

Lead Contracts Analyst